SKIP AHEAD:\r<br>1:18 – What is the High Yield Rating\r<br>4:15 – Strategies for Biostats and Epidemiology Questions \r<br>6:02 – How many Biostats and Epidemiology Questions are on Step 1?\r<br>8:47 – Super High Yield Topics\r<br>11:22 - Medium Yield Topics\r<br>13:53 - Lower Yield Topics\r<br>14:50 - No Yield Topics\r<br>\r<br>Learn about the High Yield Rating Here \r<br>\r<br>HIGH YIELD RATING:\r<br>10 – 2x2 Table\r<br>9 – Bias & Study Design (3-Randomization, 2 – Sampling & Selection Bias, 1 – Blinding & Placebo)\r<br>9 – Sensitivity & Specificity \r<br>9 – Type of Study Design (6-Cohort, 4-Case-Control, 4-RCT)\r<br>9 – Prevalence & Incidence\r<br>6 – p-Value and Statistical Significance \r<br>6 – Positive & Negative Predictive Value\r<br>6 – Relative Risk and Odds Ratio\r<br>4 – Confidence Interval\r<br>4 – Central Tendency (2-Mean, median and Mode, 1-Robustness, 1-Skew)\r<br>4 – Standard Deviation\r<br>3 – Statistical Testing\r<br>2 - # Needed to Treat/Harm\r<br>2 – Case Fatality Rate\r<br>2 – Power\r<br>1 – Absolute Risk Reduction and Attributable Risk\r<br>\r<br>NO YIELD (HYR of 0):\r<br>Kaplan-Myer Curves\r<br>ROC curves\r<br>Correlation coefficient & regression\r<br>Precision and accuracy\r<br>Different levels of prevention \r<br>Phases of Clinical trials\r<br>Range and interquartile range\r<br>Z-scores\r<br>Pre Test and Post Test probability \r<br>Intention to treat vs. per protocol \r<br>Blocking (type of randomization)\r<br>Allocation Concealment\r<br>Hawthorne Effect and Observer expectancy bias\r<br>Lead time and length time bias\r<br>Funnel plot & publication bias\r<br>Forrest plot\r<br>PICO \r<br>Subgroup analysis\r<br>Surrogate, Clinical and Composite Outcomes\r<br>Hazard Ratio
